Clinical Trials Logo
  1. Home
  2. Scleroderma, Systemic
  3. NCT05171114

Scleroderma: Functional Disability Between the Dominant and Contralateral Hand. — SCLERO-HAND  

Scleroderma, Systemic Clinical Trial

Official title:
Scleroderma: Description of Functional Disability Between the Dominant and Contralateral Hand, a Single-centre Descriptive Cohort.

Clinical Trial Summary

Systemic sclerosis is an autoimmune disease in which the hand is responsible for 75% of the overall disability. Management is based on systemic treatments combined with kinesitherapy aimed at maintaining joint amplitudes, improving muscle strength and preventing stiffness. The aim of this study is to describe and compare the average spontaneous and attempted reduction range of motion limitations between the dominant and contralateral hand.

Clinical Trial Description

Systemic sclerosis is an autoimmune disease in which the hand is responsible for 75% of the overall disability. In case of limitation, the level of skin fibrosis, Raynaud's syndrome and its complications, the search for painful joints with or without synovitis, and the presence of calcifications must therefore be assessed. Management is based on systemic treatments combined with kinesitherapy aimed at maintaining joint amplitudes, improving muscle strength and preventing stiffness. No study to date has compared the functionality of one hand to the other. The hypothesis is that there is a difference in range of motion limitations between the dominant hand and the contralateral hand. Patients in the active file of the Internal Medicine A department of the Limoges University Hospital who meet the inclusion criteria will be offered the study by telephone. Patients wishing to participate will be given an appointment on a dedicated consultation slot. During this visit, Patients will be given an information note and their consent will be collected. The study examinations will be performed and the questionnaire completed. At the end of this visit, the study will be completed for the patient. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05171114
Study type Interventional
Source University Hospital, Limoges
Contact
Status Completed
Phase N/A
Start date December 28, 2021
Completion date April 22, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT03965780 - The SPIN - Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED) N/A
Terminated NCT02558543 - Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis Phase 2
Withdrawn NCT01202045 - Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients N/A
Terminated NCT01445821 - Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial Phase 3
Recruiting NCT05878717 - A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease Phase 3
Recruiting NCT03559465 - Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis. N/A
Not yet recruiting NCT03610217 - Pragmatic Clinical Trials in Scleroderma N/A
Completed NCT02655640 - The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis N/A
Completed NCT05622578 - Phenotyping of Chronic Pain in Diffused Systemic Scleroderma N/A
Recruiting NCT04804930 - Trichoscopy and Systemic Scleroderma
Completed NCT03675581 - A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) Phase 1
Completed NCT03221257 - Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate Phase 2
Recruiting NCT05559580 - A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms Phase 2
Completed NCT00442611 - A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) Phase 1/Phase 2
Completed NCT00001330 - Study of Silicone-Associated Connective Tissue Diseases N/A
Completed NCT02597933 - A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis Phase 3
Not yet recruiting NCT05821335 - Leap Motion Based Gamefication Exercises in the Individuals With Systemic Sclerosis N/A
Completed NCT00333437 - Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement N/A
Completed NCT00025818 - Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome Phase 3
Not yet recruiting NCT05351060 - Novel Splinting Technique Using 3D Models N/A